RGTA11, a new healing agent, triggers developmental events during healing of craniotomy defects in adult rats

Growth Factors

Volumn 16, Issue 1, 1998, Pages 23-38

  Lafont, J ^a,c   Baroukh, B ^a   Berdal, A ^a   Colombier, M L ^a   Barritault, D ^b   Caruelle, J P ^b   Saffar, J L ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Université Paris XII ^*  (France)

^c UNIV MONTPELLIER   (France)

Author keywords

Bone healing; Craniotomy; Extracellular matrix; Healing agent; Osteoblast; RGTA; Suture reformation

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; FIBROBLAST GROWTH FACTOR; FIBRONECTIN; GROWTH FACTOR; MATRIX PROTEIN; OSTEOCALCIN; RGTA 11; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; BONE REGENERATION; CONTROLLED STUDY; CRANIOTOMY; EXTRACELLULAR MATRIX; FRACTURE HEALING; HEALING; MALE; MUSCLE; NERVE; NONHUMAN; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SKIN; TISSUE REPAIR; WOUND CLOSURE;

ANIMALIA;

EID: 0031772189     PISSN: 08977194     EISSN: None     Source Type: Journal    
DOI: 10.3109/08977199809017489     Document Type: Article

References (59)

1. Aamiri, A., Mobarek, A., Carpentier, G., Barritault, D. and Gautron, J. (1995) Effets d'un dextrane substitué sur la réinnervation du muscle squelettique du rat adulte au cours de la régénération. C.R. Acad. Sci., Paris 318, 1037-1043.
2. Alberius, P. and Johnell, O. (1990) Immunohistochemical assessment of cranial suture development in rats. J. Anal. 173,61-68.
3. Albo, D., Long, C., Jhala, N., Atkinson, B., Granik, M.S., Wang, T., Meddahi, A., Barritault, D. and Solomon, M.P. (1996) Modulation of cranial bone healing with a heparin-like dextran derivative. J. Craniofac. Surg. 7, 19-22.
4. Andrew, J.G., Hoyland, J., Andrew, S.M., Freemont, A.J. and Marsh, D. (1993) Demonstration of TGF-betal messenger RNA by in situ hybridization in normal human fracture healing. Calcif. Tissue Int. 52, 74-78.
5. Beck, L.S., Deguzman, L., Lee, W.P., Xu, Y., McFatridge, L.A., Gillett, N.A. and Amento, E.P. (1991) TGF-ßl induces bone closure of skull defects. J. Bone Miner. Res. 6, 1257-1265.
6. Benazzoug, Y., Logeart, D., Labat-Robert, J., Robert, L., Jozefonvicz, J. and Kern, P. (1995) Derivatized dextrans modulates collagen synthesis in aortic smooth muscle cells. Biochem. Pharmacol. 49, 847-853.
7. Berdal, A., Balmain, N., Bréhier, A., Hotton, D., Cuisinier-Gleizes, P. and Mathieu, H. (1989) Immunological characterization, developmental pattern and vitamin D-dependency of calbindin-D-28k in rat teeth ameloblasts. Differentiation 40, 27-35.
8. Bianco, P., Silvestrini. G., Termine, J.D. and Bonucci, E. (1988) Immunohistochemical localization of osleonectin in developing human and calf bone using monoclonal antibody. Calcif. Tissue Int. 43, 155-161.
9. Blanquaert, F., Saffar, J.L., Colombier, M.L., Carpentier, G., Barritault, D. and Caruelle, J.P. (1995) Heparan-like molecules induce the repair of skull defects. Bone 17, 499-506.
10. Bostrom, M.P.G., Lane, J.M., Berberian, W.S., Missri, A.A.E., Tomin, E., Weiland, A., Doty, S.B., Glaser, D. and Rosen, V.M. (1995) Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. J. Orthop. Res. 13, 357-367.
11. Bourque, W.T., Gross, M. and Hall, B.K., (1993) Expression of four growth factors during fracture repair. Int. J. Dev. Biol. 37, 573-579.
12. Bronckers, A.L.J.J., Gay, S., Finkelman, R.D. and Butler, W.T. (1987) Developmental appearance of Gla proteins (osteocalcin) and alkaline phosphatase in tooth germs and bones of the rat. Bone Miner. 2, 361-373.
13. Bruder, S.P., Fink, D.J. and Caplan, A.I. (1994) Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J. Cell Biochem. 56, 283-294.
14. Burgess, W.H. and Maciag, T. (1989) The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 58, 575-606.
15. Camarda, A.J., Butler, W.T., Finkelman, R.D. and Nanci, A. (1987) Immunocytochemical localization of g-carboxyglutamic acid-containing proteins (osteocalcin) in rat bone and dentin. Calcif. Tissue Int. 40, 349-355.
16. de Pollack, C., Renier, D., Hott, M. and Marie, P.J. (1996) Increased bone formation and osteoblastic cell phenotype in premature cranial suture ossification (craniosynostosis). J. Bone Miner. Res. 11, 401-407.
17. Dufour, S., Duband, J.L. and Thiery, J.P. (1988) Fibronectin in embryonic cell motility. In Structure and Functions of the Cytoskeleton, B.A.F. Rousset, ed., INSERM-Libbey Eurotext, Paris, pp. 101-112.
18. Fredj-Reygrobellet, D., Hristova, D.L., Ettaiche, M., Meddahi, A., Jozefonwicz, J. and Barritault, D. (1994) CMDBS, functional analogue of heparin sulfate as a new class of corneal ulcer healing agents. Ophthalmic Res. 26, 325-331.
19. Gautron, J., Kedzia, C., Husmann, I. and Barritault, D. (1995) Accélération de la régénération d'un muscle squelettique de rat adulte par des dérivés de dextranes. C.R. Acad. Sci., Paris 318, 671-676.
20. Gorter de Vries, I., Quartier, E., Boute, P., Wisse, E. and Coomans, D. (1987) Immunocytochemical localization of osteocalcin in developing rat teeth. J. Dent. Res. 66, 784-790.
21. Gospodarowicz, D. and Cheng, J. (1986) Heparin protects basic and acidic FGF from inactivation. J. Cell. Physiol. 128, 475-484.
22. Henricson, A., Hulth, A. and Johnell, O. (1987) The cartilaginous fracture callus in rats. Acta Orthop. Scand. 58, 244-248.
23. Hiltunen, A., Aro, H.T. and Vuorio, E. (1993) Regulation of extracellular matrix genes during fracture healing in mice. Clin. Orthop. 297, 23-27.
24. Hobar, P.C., Schreiber, J.S., McCarthy, J.G. and Thomas, P.A. (1993) The role of the dura in cranial bone regeneration in the immature animal. Plast. Reconstr. Surg. 92, 405-410.
25. Joyce, M.E., Heydemann, A. and Bolander, M.E. (1990) Platelet-derived growth factor regulates the initiation of fracture repair. Orthop. Trans. 14, 363.
26. Kawaguchi, H., Kurokawa, T., Hanada, K., Hiyama, Y., Tamura, M., Ogata, E. and Matsumoto, T. (1994) Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology 135, 774-781.
27. Lafont, J., Baroukh, B., Meddahi, A., Caruelle, J.P., Barritault, D. and Saffar, J.L. (1994) Derivatized dextrans (CMDBS) as promoters of bone healing. Factors influencing their effectiveness. Cells Mater. 4, 219-230.
28. Lane, J.M., Suda, M., von der Mark, K. and Timpl, R. (1986) Immunofluorescent localization of structural collagen types in endochondral fracture repair. J. Orthop. Res. 4, 318-329.
29. Larjava, H., Sandberg, M., Happonen, R.P. and Vuorio, E. (1990) Differential localization of type I and type III procollagen messenger ribonucleic acids in inflamed periodontal and periapical connective tissues by in situ hybridization. Lab. Invest. 62, 96-103.
30. Liu, C., Sanghevi, R., Burnell, J.M. and Howard, G.A. (1987) Simultaneous demonstration of bone alkaline and acid phosphatas̀ activities in plastic-embedded sections and differential inhibition of these activities. Histochemistry 86, 559-565.
31. Majack, R.A. and Bornstein, P. (1985) Heparin regulates the collagen phenotype of vascular smooth muscle cells; induced synthesis of an Mr 60.000 collagen. J. Cell Biol. 100, 613-619.
32. Majeska, R.J., Port, M. and Einhorn, T.A. (1993) Attachment to extracellular matrix molecules by cells differing in the expression of osteoblastic traits. J. Bone Miner. Res. 8, 277-289.
33. Majmudar, G., Bole, D., Goldstein, S.A. and Bonadio, J. (1991) Bone cell culture in a three-dimensional polymer bead stabilizes the differentiated phenotype and provides evidence that osteoblastic cells synthesize type-III collagen and fibronectin. J. Bone Miner. Res. 6, 869-881.
34. Mark, M.P., Butler, W.T., Prince, C.W., Finkelman, R.D. and Ruch, J.V. (1988) Developmental expression of 44-kDa bone phosphoprotein (osteopontin) and bone g-carboxyglutamic acid (Gla)-containing protein (osteocalcin) in calcifying tissues of rat. Differentiation 37, 123-136.
35. Mauzac, M., Maillet, F., Joszefonvicz, J. and Kazatchkine, M.D. (1985) Anticomplementary activity of dextran derivatives. Biomaterials 6, 61-63.
36. McCaffrey, Y., Falcone, D. and Du, B. (1992) Transforming growth factor ßl is a heparin-binding protein: identification putative heparin-binding regions and isolation of heparin with varying affinity for TGF-ßl. J. Cell. Physiol. 152, 430-440.
37. McCaffrey, Y., Falcone, D., Vicente, D., Du, B., Consigli, S. and Borth, W. (1994) Protection of transforming growth factor ßl activity by heparin and fucoidan. J. Cell. Physiol. 159, 51-59.
38. Meddahi, A., Blanquaert, F., Saffar, J.L., Colombier, M.L., Caruelle, J.P., Josefonvicz, J. and Barritault, D. (1994) New approaches to tissue regeneration and repair. Pathol. Res. Pract. 190, 923-928.
39. Meddahi, A., Lemdjabar, H., Caruelle, J.P., Barritault, D. and Hornebeck, W. (1995) Inhibition by dextran derivatives of FGF-2 plasmin-mediated degradation. Biochimie 77, 703-706.
40. Meddahi, A., Benoit, J., Ayoub, R., Sézeur, A. and Barritault, D. (1996a) Heparin-like polymers derived from dextran enhance colonie anastomosis resistance to leakage. J. Biomed. Mater. Res. 31, 293-297.
41. Meddahi, A., Lemdjabar, H., Caruelle, J.P., Barritault, D. and Hornebeck, W. (1996b) FGF protection and inhibition of human neutrophil elastase by carboxymethyl benzylamide sulfonate dextran derivatives. Int. J. Biol. Macromol. 18, 141-145.
42. Mörike, M., Schulz, M., Nerlich, A., Koschnik, M., Teller. W.M., Vetter, U. and Brenner, R.E. (1995) Expression of osteoblastic markers in cultured human bone and fracture callus cells. J. Mol. Med. 73, 571-575.
43. Moursi, A.M., Damsky, C.H., Lull, J., Zimmerman, D., Doty, S.B., Aota, S.I. and Globus, R.K. (1996) Fibronectin regulates calvarial ostcoblast differentiation. J. Cell Sci. 109, 1369-1380.
44. Nordahl, J., Mengarelli-Widholm, S., Hultenby, K. and Reinholt, F.P. (1995) Ultrastructural immunolocalization of fibronectin in epiphyseal and metaphyseal bone of young rats. Calcif. Tissue Int. 57, 442-449.
45. Opperman, L.A., Passarelli, R.W., Morgan, E.P., Reintjes, M. and Ogle, R.C. (1995) Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro. J. Bone Miner. Res. 10, 1978-1987.
46. Opperman, L.A., Passarelli, R.W., Nolen, A.A., Gampper, T.J., Lin, K. Y.K. and Ogle, R.C. (1996) Dura mater secretes soluble heparin-binding factors required for cranial suture morphogenesis. In Vitro Cell. Dev. Biol.-Animal 32, 627-632.
47. Owen, T.A., Aronow, M., Shalhoub, V., Barone, L.M., Wilming, L., Tassinari, M.S., Kennedy, M.B., Pockwinse, S., Lian, J.B. and Stein, G.S. (1990) Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J. Cell. Physiol. 143, 420-430.
48. Page, M., Hogg, J. and Ashhurst, D.E. (1986) The effects of mechanical stability on the macromolecules of the connective tissue matrices produced during fracture healing. I. The collagens. Histochem. J. 18, 251-265.
49. Paralkar, V.M., Nandedkar, A.K.N., Pointer, R.H., Kleinman, H.K. and Reddi, A.H. (1990) Interaction of osteogenin, a heparin binding bone morphogenetic protein, with type-IV collagen. J. Biol. Chem. 265, 17281-17284.
50. Ruoslahti, E., Hayman, E.G., Pierschbacher, M. and Engvall, E. (1982) Fibronectin: purification, immunochemical properties and biological activities. Methods Enzymol. 82, 803-831.
51. Rusnati, M. and Presta, M. (1996) Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Biological implications in neovascularization. Int. J. Clin. Lab. Res. 26, 15-23.
52. Saksela, O., Moscatelli, D., Sommer, A. and Rifkin, D.B. (1988) Endothelial cell-derived heparan sulfate binds basic Fibroblast Growth Factor and protects it from proteolytic degradation. J. Cell. Biol. 107, 743-751.
53. Sandberg, M.M., Aro, H.T. and Vuorio, E.I. (1993) Gene expression during bone repair. Clin. Orthop. 289, 292-312.
54. Tardieu, M., Slaoui, F., Jozefonvicz, J., Courty, J., Gamby, C. and Barritault, D. (1989) Biological and binding studies of acidic fibroblast growth factor in the presence of substituted dextran. J. Biomat. Sci. (Polymer edition) 1, 63-70.
55. Tardieu, M., Gamby, C., Avramoglou, T., Jozefonvicz, J. and Barritault, D. (1992) Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGF. J. Cell. Physiol. 150, 194-203.
56. Toriumi, D.M., Kotler, H.S., Luxenberg, D.P., Hoitrop, M.E. and Wang, E.A. (1991) Mandibular reconstruction with a recombinant bone-inducing factor - Functional, histologic, and biomechanical evaluation. Arch. Otolaryngol. Head Neck Surg. 117, 1101-1112.
57. Weinreb, M., Shinar, D. and Rodan, G.A. (1990) Different pattern of alkaline phosphatase, osteopontin, and osteocalcin expression in developing rat bone visualised by in situ hybridization. J. Bone Miner. Res. 5, 831-842.
58. Wolf, E., Roser, K., Hahn, M., Welkerling, H. and Delling, G. (1992) Enzyme and immunohistochemistry on undecalcified bone and bone marrow biopsies after embedding in plastic - A new embedding method for routine application. Virchows Arch. A 420, 17-24.
59. Zamboni, L. and di Martino, C. (1967) Buffered picric acidformaldehyde: a new rapid fixative for electron microscopy. J. Cell Biol. 35, 148.